PROGRESSIVE PULMONARY FIBROSIS
Clinical trials for PROGRESSIVE PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow lung decline in scarring disease
Disease control Not yet recruitingThis Phase 3 trial tests whether HSK44459 tablets can slow the decline in lung function for adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. About 378 participants will take the drug or a placebo twice daily for 52 weeks. The main goa…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Hands-On therapy tested for lung disease: could osteopathic techniques ease breathing?
Symptom relief Not yet recruitingThis study tests whether adding osteopathic manipulative techniques (gentle hands-on bodywork) to standard chest physiotherapy can improve lung function and reduce shortness of breath in people with progressive pulmonary fibrosis. Fifty adults with advanced lung scarring will rec…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC